Latent-CURE for Breast Cancer Diagnosis
Abstract
Multimodal Large Models have significantly advanced automated breast ultrasound diagnosis. However, most existing frameworks utilize opaque, end-to-end paradigms prioritizing global statistical correlations over structured clinical reasoning. Consequently, these models remain susceptible to shortcut learning amid extreme real-world epidemiological imbalances, often bypassing rare but decisive malignant indicators for dominant benign patterns. To address this disconnect, we propose Latent-CURE, a novel diagnostic framework driven by asymmetric weighted chain-of-thought methodology grounded in latent space reasoning. Unlike traditional approaches, our framework constructs an implicit reasoning trajectory forcing the model to sequentially infer standardized BI-RADS morphological descriptors before converging on a final diagnosis. Furthermore, to combat the extreme scarcity of critical malignant features, we couple this architecture with a dual-asymmetric optimization strategy. By dynamically adjusting margins and weights, this strategy safeguards high-specificity malignant descriptors from being overshadowed by common benign priors. Comprehensive evaluations demonstrate that our knowledge-injected approach provides transparent clinical evidence while achieving robust, accurate diagnostic performance in imbalanced medical cohorts.
Keywords
Cite
@article{arxiv.2606.29928,
title = {Latent-CURE for Breast Cancer Diagnosis},
author = {Weiyi Zhao and Xiaoyu Tan and Lu Gan and Liang Liu and Xihe Qiu},
journal= {arXiv preprint arXiv:2606.29928},
year = {2026}
}
Comments
11 pages, 4 figures, 3 tables. Accepted to MICCAI 2026